|drug3652||Walk Test Wiki||1.00|
|drug1927||MRI (heart, brain, lungs, liver) Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
There is one clinical trial.
Endoscopic methods are frequently used in the diagnosis of gastrointestinal system pathologies in children.
Description: The number of participiants who had Covid-19 infection after the endoscopic procedures.Measure: The number of participiants who was infected with Covid-19. normalization process of Covid-19 pandemic Time: 14 days
Description: The developed time of covid 19 infection after the endoscopic procedures in participiants.Measure: The time of seen covid 19 infection after the endoscopic procedures in participiants. Time: 14 days
Description: The characteristics of patients with Covid-19 infection after the endoscopic procedures in participiants.Measure: The characteristics of patients with Covid-19 infection. Time: 14 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports